66 days and counting – No Cavaltinib trial newsI emailed Mr. Gordon on December 28 2020 but have not responded to date..... Have they advanced funds to Biologic Pharmamedical Research (Plasm Pharmaceutical Inc.("PLASM")? "Dear Mr. Goodwin, if you would be so kind as to provide me with an update concerning the Joint Venture related to Cavaltinib and how the terms noted below are progressing. Have you advanced all the funds of $500K to Biologic Pharmamedical Research?
"Under the terms of the joint venture, Naturally Splendid will invest $500,000 CDN for:
(a) preparing documentation for submission of the CTA to Health Canada.
(b) preparation of formal phase 2 clinical trials
(c) $100,000 CDN for inventory of the COVID-19 treatment product for phase 2 clinical trials;
(d) ongoing clinical trials and further research and development for a period of twelve (12) months overseen by Biologic; and
(e) preparing documentation for pre-IND application for a phase 2 COVID-19 clinical trial with the U.S. FDA.
(f) preparing and executing our own internal pilot trial"
I'll look forward to your response.
Regards"
G1945V